Selling Stockholder Registers Resale of 255,103 Shares from December 2025 Private Placement
ALLR sits 80% above its 52-week low of $0.769.
Summary
An institutional investor, 3i, LP, is registering 255,103 shares for resale, which were acquired in a December 2025 private placement, potentially adding selling pressure to the stock.
Key Events · Financing and Capital Events · ALLR
-
Resale of Shares Registered
Selling stockholder 3i, LP has registered 255,103 shares of common stock for resale. The company will not receive any proceeds from these sales.
-
Shares from December 2025 Private Placement
The shares being registered for resale were originally issued to 3i, LP in a private placement completed on December 23, 2025, at a price of $0.98 per share.
-
Potential Market Overhang
The potential sale of these shares, valued at approximately $357,144 based on the last reported price, represents about 1.68% of the company's current market capitalization, which could exert downward pressure on the stock.
Analysis · ALLR · Life Sciences
This 424B3 prospectus details the registration for resale of 255,103 common shares by selling stockholder 3i, LP. These shares were originally acquired in a private placement on December 23, 2025, at $0.98 per share. While the company will not receive any proceeds from this resale, the potential sale of shares representing approximately 1.68% of the current market capitalization by an institutional investor could create an overhang on the stock, especially for a company of this size. This follows the S-3/A filing on April 24, 2026, which likely initiated the shelf registration process for these shares.
At the time of this filing, ALLR was trading at $1.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.2M. The 52-week trading range was $0.77 to $2.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.